Brexpiprazole With Antidepressants for Agitation in Alzheimer’s Dementia: Post Hoc Analysis
C. Brendan Montano, Sanjeda R Chumki, David Wang, Anton M. Palma et autres
0 citationsAmerican Journal of Geriatric Psychiatry
Anton M. Palma
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
73Publications signalées
879Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
HIV/AIDS Research and InterventionsDementia and Cognitive Impairment ResearchSchizophrenia research and treatmentSARS-CoV-2 and COVID-19 ResearchHealthcare Decision-Making and Restraints
Publications récentes
The importance of patient life engagement as a treatment goal in adults living with schizophrenia: a plain language summary
Zahinoor Ismail, Stine R. Meehan, Anja Farovik, Shivani Kapadia et autres
0 citationsCurrent Medical Research and Opinion
Brexpiprazole for Agitation in Patients with Alzheimer’s Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials
Pierre Tariot, Sanjeda Chumki, David Wang, Pedro Such et autres
0 citationsDove Medical Press (Taylor and Francis Group)
Brexpiprazole for Agitation in Patients with Alzheimer’s Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials
Pierre Tariot, Sanjeda Chumki, David Wang, Pedro Such et autres
0 citationsNeuropsychiatric Disease and Treatment
Brexpiprazole for agitation in clinically relevant patient subgroups: a post hoc analysis of efficacy and safety in patients with agitation associated with dementia due to Alzheimer’s disease
Jared Stroud, Jeffrey L. Cummings, Sanjeda R Chumki, Pedro Such et autres
7 citationsCurrent Medical Research and Opinion
Brexpiprazole for anxiety symptoms in schizophrenia: a pooled analysis of short- and long-term trials
Zahinoor Ismail, Shivani Kapadia, Anton M. Palma, Murat Yildirim et autres
2 citationsCurrent Medical Research and Opinion
117. VALIDATION OF THE AGITATION IN ALZHEIMER’S SCREENER FOR CAREGIVERS (AASC®), A NOVEL CLINICAL TOOL TO SCREEN FOR AGITATION IN ALZHEIMER’S DEMENTIA
George T. Grossberg, Will Jackson, Malaak Brubaker, Iwona Bucior et autres
0 citationsAmerican Journal of Geriatric Psychiatry
28. BREXPIPRAZOLE FOR AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE: NUMBER NEEDED TO TREAT, NUMBER NEEDED TO HARM, AND LIKELIHOOD TO BE HELPED OR HARMED
Leslie Citrome, Sanjeda R Chumki, Pedro Such, David Wang et autres
0 citationsAmerican Journal of Geriatric Psychiatry
Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of clinical trials in adults and adolescents
Christoph U. Correll, B. Pflug, Zhen Zhang, Anton M. Palma et autres
0 citationsEuropean Psychiatry
Effects of brexpiprazole on patient life engagement in schizophrenia: post hoc analysis of Positive and Negative Syndrome Scale data
Zahinoor Ismail, Stine R. Meehan, Anja Farovik, Anton M. Palma et autres
7 citationsCurrent Medical Research and Opinion
Efficacy of brexpiprazole on agitation in patients with dementia due to Alzheimer’s disease exhibiting behaviors most bothersome to caregivers: post hoc pooled analysis of two randomized controlled trials
Malaak Brubaker, David Wang, Sanjeda R Chumki, Pedro Such et autres
1 citationAlzheimer s & Dementia
Sustained clinically meaningful response in patients with agitation associated with dementia due to Alzheimer’s disease treated with brexpiprazole: post hoc analysis
Malaak Brubaker, David Wang, Sanjeda R Chumki, Pedro Such et autres
0 citationsAlzheimer s & Dementia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.